Regulus Therapeutics Inc. - RGLS

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No sell transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
06/03/2025	06/04/2025	Klassen Preston President & Head of R & D Officer Director	Buy	12,000 @ $7.99	$95,852.40	48,055	(33.28%)	Direct